deltatrials
Completed PHASE2 NCT00196885

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Effect of N-Acetylcysteine on Skeletal Muscle in Cachectic Cancer Patients Undergoing a Resistance Training Program (Phase 2 Study)

Sponsor: German Cancer Research Center

Conditions Bronchial Carcinoma Gastrointestinal Neoplasms Hodgkin Disease Non-Hodgkin Lymphoma Weight Loss
Interventions N-acetylcysteine
Updated 5 times since 2017 Last updated: Jun 18, 2008 Started: Dec 31, 2003 Completion: Dec 31, 2006

A PHASE2 clinical study on Bronchial Carcinoma and Gastrointestinal Neoplasms, this trial is completed. The trial is conducted by German Cancer Research Center and has accumulated 5 data snapshots since 2003. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • German Cancer Research Center
  • Heidelberg University
Data source: German Cancer Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Heidelberg, Germany